OBJECTIVES: To assess the prevalence of Parkinson's disease and parkinsonism in two Spanish populations (Irun and Hondarribia, Bidasoa Region) and to compare the results with those of similar surveys. METHODS: The survey included 2000 participants aged 65 years or older in a door-to-door, three-phase design. In the screening phase we used the SNES (Sicilian Neuro-Epidemiologic Study) screening questionnaire, which has 100% sensitivity. In phases 2 and 3 we carried out a 3-year follow-up of all cases diagnosed with parkinsonism in phase 2. Progressively stricter diagnostic criteria were chosen in order to minimize the impact of false positives on the final results. RESULTS: The prevalence of Parkinson's disease (PD) was 1.5 % (95% confidence interval, 0.9 to 2.3) and the prevalence of other types of parkinsonism (OP) was 1.1 % (95% confidence interval 0.6 to 1.9). The overall prevalence by age group was 0.4 % (65-74 years), 4.7% (75-84 years), and 2.9% (> or =85 years) for Parkinson's disease and 0.7%, 2%, and 3.9 % for parkinsonism, respectively. The other parkinsonism prevalence was 1.3 % in men and 1.6 % in women. CONCLUSIONS: These prevalence rates are similar than those found in studies made in other European countries. The prevalence of both Parkinson's disease and other types of parkinsonism increased with age, with no significant differences between men and women.
OBJECTIVES: To assess the prevalence of Parkinson's disease and parkinsonism in two Spanish populations (Irun and Hondarribia, Bidasoa Region) and to compare the results with those of similar surveys. METHODS: The survey included 2000 participants aged 65 years or older in a door-to-door, three-phase design. In the screening phase we used the SNES (Sicilian Neuro-Epidemiologic Study) screening questionnaire, which has 100% sensitivity. In phases 2 and 3 we carried out a 3-year follow-up of all cases diagnosed with parkinsonism in phase 2. Progressively stricter diagnostic criteria were chosen in order to minimize the impact of false positives on the final results. RESULTS: The prevalence of Parkinson's disease (PD) was 1.5 % (95% confidence interval, 0.9 to 2.3) and the prevalence of other types of parkinsonism (OP) was 1.1 % (95% confidence interval 0.6 to 1.9). The overall prevalence by age group was 0.4 % (65-74 years), 4.7% (75-84 years), and 2.9% (> or =85 years) for Parkinson's disease and 0.7%, 2%, and 3.9 % for parkinsonism, respectively. The other parkinsonism prevalence was 1.3 % in men and 1.6 % in women. CONCLUSIONS: These prevalence rates are similar than those found in studies made in other European countries. The prevalence of both Parkinson's disease and other types of parkinsonism increased with age, with no significant differences between men and women.
Authors: Katerina Mensikova; Petr Kanovsky; Michaela Kaiserova; Lenka Mikulicova; Miroslav Vastik; Petr Hlustik; Petr Jugas; Josef Ovecka; Vladimír Janout Journal: Eur J Epidemiol Date: 2013-07-26 Impact factor: 8.082
Authors: Jesús de Pedro-Cuesta; Javier Virués-Ortega; Saturio Vega; Manuel Seijo-Martínez; Pedro Saz; Fernanda Rodríguez; Angel Rodríguez-Laso; Ramón Reñé; Susana Pérez de las Heras; Raimundo Mateos; Pablo Martínez-Martín; José María Manubens; Ignacio Mahillo-Fernandez; Secundino López-Pousa; Antonio Lobo; Jordi Llinàs Reglà; Jordi Gascón; Francisco José García; Manuel Fernández-Martínez; Raquel Boix; Félix Bermejo-Pareja; Alberto Bergareche; Julián Benito-León; Ana de Arce; José Luis del Barrio Journal: BMC Neurol Date: 2009-10-19 Impact factor: 2.474
Authors: Lianna S Ishihara; Kay-Tee Khaw; Robert Luben; Sheila Bingham; Ailsa Welch; Nicholas Day; Carol Brayne Journal: BMC Neurol Date: 2005-08-24 Impact factor: 2.474
Authors: Raquel Boix; José Luis del Barrio; Pedro Saz; Ramón Reñé; José María Manubens; Antonio Lobo; Jordi Gascón; Ana de Arce; Jaime Díaz-Guzmán; Alberto Bergareche; Félix Bermejo-Pareja; Jesús de Pedro-Cuesta Journal: BMC Neurol Date: 2006-10-16 Impact factor: 2.474
Authors: Pierre O Poliquin; Jingkui Chen; Mathieu Cloutier; Louis-Éric Trudeau; Mario Jolicoeur Journal: PLoS One Date: 2013-07-23 Impact factor: 3.240
Authors: Hamdy N El-Tallawy; Wafaa M Farghaly; Ghaydaa A Shehata; Tarek A Rageh; Nabil M Abdel Hakeem; Mohamed Abd Al Hamed; Reda Badry Journal: Neuropsychiatr Dis Treat Date: 2013-11-26 Impact factor: 2.570